Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT43 | Individual Protein | Tyrosinase | Agaricus bisporus | Inhibition | = | 5.21 | % | 17287127 |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT1224 | Individual Protein | Glyceraldehyde-3-phosphate dehydrogenase liver | Homo sapiens | Potency | = | 8191.1 | nM | PubChem BioAssay data set |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 501.2 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT2796 | Individual Protein | Apoptosis regulator Bcl-X | Homo sapiens | IC50 | > | 108803 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT52 | Individual Protein | Pyruvate kinase isozymes M1/M2 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 3981.1 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT57 | Individual Protein | Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens | IC50 | = | 18751 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT714 | Individual Protein | Fructose-bisphosphate aldolase A | Oryctolagus cuniculus | Potency | = | 18337.5 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 20575 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 6294.6 | nM | PubChem BioAssay data set |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 35610 | nM | PubChem BioAssay data set | |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT58 | Individual Protein | Bloom syndrome protein | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 40163 | nM | PubChem BioAssay data set | |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 2238.7 | nM | PubChem BioAssay data set |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT798 | Individual Protein | Alkaline phosphatase placental-like | Homo sapiens | EC50 | = | 59600 | nM | PubChem BioAssay data set |
NPT801 | Individual Protein | Intestinal alkaline phosphatase | Homo sapiens | EC50 | = | 81000 | nM | PubChem BioAssay data set |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT802 | Individual Protein | Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens | EC50 | = | 43400 | nM | PubChem BioAssay data set |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT799 | Individual Protein | Intestinal alkaline phosphatase | Mus musculus | EC50 | 71900 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 1584.9 | nM | PubChem BioAssay data set | |
NPT917 | Individual Protein | Dengue virus type 2 NS3 protein | Dengue virus type 2 (strain Thailand/16681/1984) (DENV-2) | IC50 | > | 100000 | nM | PubChem BioAssay data set |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT534 | Individual Protein | Phosphoglycerate kinase, glycosomal | Trypanosoma brucei brucei | Potency | 4466.8 | nM | PubChem BioAssay data set | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 63020 | nM | PubChem BioAssay data set | ||
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 7079.5 | nM | PubChem BioAssay data set | ||
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 7079.5 | nM | PubChem BioAssay data set | |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | > | 94228 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT1854 | Individual Protein | Phosphoglycerate kinase | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Potency | 919 | nM | PubChem BioAssay data set | |
NPT589 | Individual Protein | Serum albumin | Bos taurus | IC50 | > | 94228 | nM | PubChem BioAssay data set |
NPT4407 | Individual Protein | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Homo sapiens | Ki | = | 1290 | nM | 24398380 |
NPT4407 | Individual Protein | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Homo sapiens | IC50 | = | 2970 | nM | 24398380 |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 4744.4 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 53655 | nM | PubChem BioAssay data set | ||
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 5358.2 | nM | PubChem BioAssay data set | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 4466.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 340.9 | nM | PubChem BioAssay data set | ||
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 7519.3 | nM | PubChem BioAssay data set | |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT1040 | Individual Protein | Human immunodeficiency virus type 1 Tat protein | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | IC50 | 74865 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 22140 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC216318 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC17286 |
1.0 | High Similarity | NPC259713 |
1.0 | High Similarity | NPC296197 |
0.993 | High Similarity | NPC45873 |
0.9861 | High Similarity | NPC225731 |
0.9859 | High Similarity | NPC130230 |
0.9859 | High Similarity | NPC275772 |
0.9859 | High Similarity | NPC239312 |
0.9793 | High Similarity | NPC131624 |
0.9793 | High Similarity | NPC275836 |
0.9793 | High Similarity | NPC293183 |
0.9793 | High Similarity | NPC275722 |
0.9793 | High Similarity | NPC198826 |
0.9793 | High Similarity | NPC256283 |
0.9793 | High Similarity | NPC120163 |
0.9793 | High Similarity | NPC162313 |
0.9793 | High Similarity | NPC212678 |
0.9793 | High Similarity | NPC25270 |
0.9793 | High Similarity | NPC241498 |
0.9793 | High Similarity | NPC188203 |
0.9793 | High Similarity | NPC57030 |
0.9793 | High Similarity | NPC239128 |
0.9793 | High Similarity | NPC222830 |
0.9793 | High Similarity | NPC71334 |
0.9793 | High Similarity | NPC187498 |
0.9793 | High Similarity | NPC156222 |
0.9793 | High Similarity | NPC83508 |
0.9793 | High Similarity | NPC27208 |
0.9793 | High Similarity | NPC301323 |
0.9793 | High Similarity | NPC100887 |
0.9792 | High Similarity | NPC61620 |
0.979 | High Similarity | NPC12367 |
0.979 | High Similarity | NPC118726 |
0.9726 | High Similarity | NPC160951 |
0.9726 | High Similarity | NPC274327 |
0.9726 | High Similarity | NPC145379 |
0.9726 | High Similarity | NPC176775 |
0.9726 | High Similarity | NPC47781 |
0.9726 | High Similarity | NPC231018 |
0.9726 | High Similarity | NPC69394 |
0.9726 | High Similarity | NPC255350 |
0.9726 | High Similarity | NPC183878 |
0.9726 | High Similarity | NPC22519 |
0.9724 | High Similarity | NPC251110 |
0.9722 | High Similarity | NPC195351 |
0.972 | High Similarity | NPC168803 |
0.966 | High Similarity | NPC2476 |
0.966 | High Similarity | NPC167815 |
0.966 | High Similarity | NPC146165 |
0.966 | High Similarity | NPC227325 |
0.966 | High Similarity | NPC4455 |
0.966 | High Similarity | NPC26227 |
0.966 | High Similarity | NPC20830 |
0.966 | High Similarity | NPC280339 |
0.966 | High Similarity | NPC92659 |
0.966 | High Similarity | NPC44079 |
0.966 | High Similarity | NPC128863 |
0.966 | High Similarity | NPC201136 |
0.966 | High Similarity | NPC213622 |
0.966 | High Similarity | NPC50715 |
0.966 | High Similarity | NPC196439 |
0.966 | High Similarity | NPC183597 |
0.966 | High Similarity | NPC201451 |
0.966 | High Similarity | NPC256612 |
0.966 | High Similarity | NPC138360 |
0.966 | High Similarity | NPC163780 |
0.9658 | High Similarity | NPC142540 |
0.9658 | High Similarity | NPC120537 |
0.9658 | High Similarity | NPC199100 |
0.9658 | High Similarity | NPC180234 |
0.9655 | High Similarity | NPC306821 |
0.9655 | High Similarity | NPC184136 |
0.9655 | High Similarity | NPC248102 |
0.9655 | High Similarity | NPC77858 |
0.9653 | High Similarity | NPC276930 |
0.9648 | High Similarity | NPC279121 |
0.9595 | High Similarity | NPC43243 |
0.9595 | High Similarity | NPC98661 |
0.9595 | High Similarity | NPC245546 |
0.9595 | High Similarity | NPC49824 |
0.9595 | High Similarity | NPC266960 |
0.9595 | High Similarity | NPC247017 |
0.9592 | High Similarity | NPC167091 |
0.9592 | High Similarity | NPC75279 |
0.9592 | High Similarity | NPC292214 |
0.9592 | High Similarity | NPC271779 |
0.9592 | High Similarity | NPC88645 |
0.9592 | High Similarity | NPC206238 |
0.9592 | High Similarity | NPC250822 |
0.9592 | High Similarity | NPC276409 |
0.9589 | High Similarity | NPC226973 |
0.9589 | High Similarity | NPC208043 |
0.9586 | High Similarity | NPC223579 |
0.9586 | High Similarity | NPC287101 |
0.9586 | High Similarity | NPC52005 |
0.9586 | High Similarity | NPC137062 |
0.9586 | High Similarity | NPC183950 |
0.9583 | High Similarity | NPC55557 |
0.9583 | High Similarity | NPC30647 |
0.9583 | High Similarity | NPC61871 |
0.958 | High Similarity | NPC70136 |
0.9577 | High Similarity | NPC175013 |
0.953 | High Similarity | NPC110070 |
0.953 | High Similarity | NPC287979 |
0.953 | High Similarity | NPC224137 |
0.953 | High Similarity | NPC203891 |
0.953 | High Similarity | NPC176665 |
0.953 | High Similarity | NPC305663 |
0.953 | High Similarity | NPC101830 |
0.953 | High Similarity | NPC93376 |
0.953 | High Similarity | NPC75215 |
0.953 | High Similarity | NPC189179 |
0.953 | High Similarity | NPC227192 |
0.953 | High Similarity | NPC470402 |
0.953 | High Similarity | NPC163524 |
0.9527 | High Similarity | NPC2928 |
0.9527 | High Similarity | NPC208197 |
0.9524 | High Similarity | NPC161277 |
0.9524 | High Similarity | NPC301123 |
0.9524 | High Similarity | NPC101996 |
0.9524 | High Similarity | NPC39732 |
0.9524 | High Similarity | NPC60972 |
0.9524 | High Similarity | NPC39007 |
0.9521 | High Similarity | NPC62042 |
0.9517 | High Similarity | NPC120464 |
0.9517 | High Similarity | NPC272721 |
0.9517 | High Similarity | NPC194856 |
0.9517 | High Similarity | NPC43669 |
0.9517 | High Similarity | NPC196277 |
0.9514 | High Similarity | NPC179271 |
0.9514 | High Similarity | NPC20791 |
0.9467 | High Similarity | NPC7846 |
0.9467 | High Similarity | NPC300943 |
0.9467 | High Similarity | NPC288669 |
0.9467 | High Similarity | NPC4481 |
0.9467 | High Similarity | NPC176300 |
0.9467 | High Similarity | NPC253634 |
0.9467 | High Similarity | NPC204854 |
0.9467 | High Similarity | NPC19687 |
0.9467 | High Similarity | NPC191459 |
0.9467 | High Similarity | NPC25495 |
0.9467 | High Similarity | NPC9609 |
0.9467 | High Similarity | NPC152166 |
0.9467 | High Similarity | NPC261004 |
0.9467 | High Similarity | NPC18772 |
0.9467 | High Similarity | NPC143828 |
0.9467 | High Similarity | NPC115798 |
0.9467 | High Similarity | NPC18607 |
0.9467 | High Similarity | NPC22472 |
0.9467 | High Similarity | NPC105242 |
0.9467 | High Similarity | NPC130894 |
0.9463 | High Similarity | NPC255106 |
0.9463 | High Similarity | NPC292107 |
0.9463 | High Similarity | NPC474520 |
0.9463 | High Similarity | NPC235165 |
0.9463 | High Similarity | NPC191146 |
0.9463 | High Similarity | NPC68093 |
0.9463 | High Similarity | NPC472916 |
0.9459 | High Similarity | NPC86485 |
0.9456 | High Similarity | NPC54394 |
0.9456 | High Similarity | NPC149614 |
0.9456 | High Similarity | NPC204515 |
0.9456 | High Similarity | NPC200740 |
0.9456 | High Similarity | NPC125062 |
0.9456 | High Similarity | NPC252933 |
0.9456 | High Similarity | NPC308451 |
0.9456 | High Similarity | NPC171010 |
0.9456 | High Similarity | NPC117579 |
0.9452 | High Similarity | NPC177298 |
0.9452 | High Similarity | NPC328119 |
0.9452 | High Similarity | NPC48479 |
0.9448 | High Similarity | NPC207729 |
0.9448 | High Similarity | NPC74881 |
0.9448 | High Similarity | NPC51443 |
0.9448 | High Similarity | NPC77378 |
0.9448 | High Similarity | NPC12200 |
0.9448 | High Similarity | NPC108406 |
0.9404 | High Similarity | NPC139036 |
0.9404 | High Similarity | NPC476980 |
0.9404 | High Similarity | NPC204290 |
0.94 | High Similarity | NPC472911 |
0.94 | High Similarity | NPC245758 |
0.94 | High Similarity | NPC472438 |
0.94 | High Similarity | NPC210084 |
0.94 | High Similarity | NPC7973 |
0.94 | High Similarity | NPC78302 |
0.94 | High Similarity | NPC156057 |
0.94 | High Similarity | NPC48208 |
0.94 | High Similarity | NPC78225 |
0.94 | High Similarity | NPC472914 |
0.94 | High Similarity | NPC29841 |
0.94 | High Similarity | NPC99597 |
0.94 | High Similarity | NPC475267 |
0.94 | High Similarity | NPC222814 |
0.94 | High Similarity | NPC472910 |
0.94 | High Similarity | NPC235215 |
0.94 | High Similarity | NPC162869 |
0.94 | High Similarity | NPC472913 |
0.94 | High Similarity | NPC474208 |
0.94 | High Similarity | NPC474836 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC216318 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9726 | High Similarity | NPD2801 | Approved |
0.9648 | High Similarity | NPD1511 | Approved |
0.9514 | High Similarity | NPD1512 | Approved |
0.9262 | High Similarity | NPD1934 | Approved |
0.8954 | High Similarity | NPD3882 | Suspended |
0.8947 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8805 | High Similarity | NPD3818 | Discontinued |
0.8766 | High Similarity | NPD3817 | Phase 2 |
0.8765 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD6166 | Phase 2 |
0.8634 | High Similarity | NPD7054 | Approved |
0.858 | High Similarity | NPD7472 | Approved |
0.8571 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8571 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8562 | High Similarity | NPD1510 | Phase 2 |
0.8543 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8542 | High Similarity | NPD943 | Approved |
0.8514 | High Similarity | NPD1549 | Phase 2 |
0.8471 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8466 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8462 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8428 | Intermediate Similarity | NPD5494 | Approved |
0.8415 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8387 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8364 | Intermediate Similarity | NPD7251 | Discontinued |
0.8313 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8302 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8291 | Intermediate Similarity | NPD5402 | Approved |
0.8288 | Intermediate Similarity | NPD1240 | Approved |
0.8264 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8261 | Intermediate Similarity | NPD1247 | Approved |
0.821 | Intermediate Similarity | NPD6232 | Discontinued |
0.8194 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD1607 | Approved |
0.8171 | Intermediate Similarity | NPD7473 | Discontinued |
0.8146 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8133 | Intermediate Similarity | NPD2796 | Approved |
0.8117 | Intermediate Similarity | NPD6799 | Approved |
0.8108 | Intermediate Similarity | NPD447 | Suspended |
0.8075 | Intermediate Similarity | NPD7075 | Discontinued |
0.8067 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8041 | Intermediate Similarity | NPD1613 | Approved |
0.8041 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8039 | Intermediate Similarity | NPD3750 | Approved |
0.8 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD230 | Phase 1 |
0.7976 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7964 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7937 | Intermediate Similarity | NPD6801 | Discontinued |
0.7914 | Intermediate Similarity | NPD919 | Approved |
0.7895 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7888 | Intermediate Similarity | NPD7819 | Suspended |
0.7857 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD2800 | Approved |
0.7853 | Intermediate Similarity | NPD3749 | Approved |
0.7848 | Intermediate Similarity | NPD5403 | Approved |
0.784 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7834 | Intermediate Similarity | NPD5401 | Approved |
0.7831 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7812 | Intermediate Similarity | NPD6599 | Discontinued |
0.7799 | Intermediate Similarity | NPD1653 | Approved |
0.7778 | Intermediate Similarity | NPD2935 | Discontinued |
0.7764 | Intermediate Similarity | NPD7411 | Suspended |
0.7712 | Intermediate Similarity | NPD3748 | Approved |
0.7711 | Intermediate Similarity | NPD6959 | Discontinued |
0.7703 | Intermediate Similarity | NPD9494 | Approved |
0.7687 | Intermediate Similarity | NPD1203 | Approved |
0.7667 | Intermediate Similarity | NPD2313 | Discontinued |
0.7628 | Intermediate Similarity | NPD1243 | Approved |
0.7625 | Intermediate Similarity | NPD920 | Approved |
0.7625 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD6559 | Discontinued |
0.7613 | Intermediate Similarity | NPD2344 | Approved |
0.761 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7603 | Intermediate Similarity | NPD9269 | Phase 2 |
0.76 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7597 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7588 | Intermediate Similarity | NPD3751 | Discontinued |
0.758 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.755 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7532 | Intermediate Similarity | NPD6190 | Approved |
0.7531 | Intermediate Similarity | NPD3226 | Approved |
0.7516 | Intermediate Similarity | NPD1933 | Approved |
0.7514 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2532 | Approved |
0.75 | Intermediate Similarity | NPD2534 | Approved |
0.75 | Intermediate Similarity | NPD2533 | Approved |
0.75 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7484 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7471 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.747 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7456 | Intermediate Similarity | NPD3787 | Discontinued |
0.7438 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD6100 | Approved |
0.7436 | Intermediate Similarity | NPD6099 | Approved |
0.7432 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7421 | Intermediate Similarity | NPD2309 | Approved |
0.7415 | Intermediate Similarity | NPD422 | Phase 1 |
0.7405 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7396 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7389 | Intermediate Similarity | NPD2346 | Discontinued |
0.7381 | Intermediate Similarity | NPD6234 | Discontinued |
0.7372 | Intermediate Similarity | NPD2799 | Discontinued |
0.7365 | Intermediate Similarity | NPD9717 | Approved |
0.7358 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7337 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7329 | Intermediate Similarity | NPD9268 | Approved |
0.731 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7297 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD3225 | Approved |
0.7257 | Intermediate Similarity | NPD5953 | Discontinued |
0.7248 | Intermediate Similarity | NPD1608 | Approved |
0.7248 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7247 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD6651 | Approved |
0.7241 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7238 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD7390 | Discontinued |
0.7219 | Intermediate Similarity | NPD1470 | Approved |
0.7216 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7208 | Intermediate Similarity | NPD3268 | Approved |
0.7208 | Intermediate Similarity | NPD411 | Approved |
0.7186 | Intermediate Similarity | NPD6844 | Discontinued |
0.7186 | Intermediate Similarity | NPD37 | Approved |
0.7181 | Intermediate Similarity | NPD1535 | Discovery |
0.7181 | Intermediate Similarity | NPD1201 | Approved |
0.7179 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD2798 | Approved |
0.716 | Intermediate Similarity | NPD4966 | Approved |
0.716 | Intermediate Similarity | NPD4965 | Approved |
0.716 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7152 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7143 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.711 | Intermediate Similarity | NPD5242 | Approved |
0.7105 | Intermediate Similarity | NPD2797 | Approved |
0.7101 | Intermediate Similarity | NPD4288 | Approved |
0.7097 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7086 | Intermediate Similarity | NPD7228 | Approved |
0.7078 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7078 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7051 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7047 | Intermediate Similarity | NPD17 | Approved |
0.7044 | Intermediate Similarity | NPD7033 | Discontinued |
0.7039 | Intermediate Similarity | NPD8312 | Approved |
0.7039 | Intermediate Similarity | NPD8313 | Approved |
0.7024 | Intermediate Similarity | NPD6386 | Approved |
0.7024 | Intermediate Similarity | NPD6385 | Approved |
0.7017 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7014 | Intermediate Similarity | NPD228 | Approved |
0.7013 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7013 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7012 | Intermediate Similarity | NPD4357 | Discontinued |
0.7006 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7 | Intermediate Similarity | NPD5353 | Approved |
0.6993 | Remote Similarity | NPD3267 | Approved |
0.6993 | Remote Similarity | NPD3266 | Approved |
0.6989 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD3764 | Approved |
0.6987 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6975 | Remote Similarity | NPD1652 | Phase 2 |
0.6975 | Remote Similarity | NPD2654 | Approved |
0.6973 | Remote Similarity | NPD4360 | Phase 2 |
0.6973 | Remote Similarity | NPD4363 | Phase 3 |
0.6971 | Remote Similarity | NPD2403 | Approved |
0.697 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6968 | Remote Similarity | NPD6777 | Approved |
0.6968 | Remote Similarity | NPD6776 | Approved |
0.6968 | Remote Similarity | NPD6779 | Approved |
0.6968 | Remote Similarity | NPD6781 | Approved |
0.6968 | Remote Similarity | NPD6780 | Approved |
0.6968 | Remote Similarity | NPD6778 | Approved |
0.6968 | Remote Similarity | NPD6782 | Approved |
0.6959 | Remote Similarity | NPD5536 | Phase 2 |
0.6957 | Remote Similarity | NPD1471 | Phase 3 |
0.6954 | Remote Similarity | NPD5710 | Approved |
0.6954 | Remote Similarity | NPD5711 | Approved |
0.694 | Remote Similarity | NPD4287 | Approved |
0.6928 | Remote Similarity | NPD1940 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD4625 | Phase 3 |
0.6913 | Remote Similarity | NPD9545 | Approved |
0.6901 | Remote Similarity | NPD2296 | Approved |
0.6899 | Remote Similarity | NPD4307 | Phase 2 |
0.6892 | Remote Similarity | NPD9493 | Approved |
0.6892 | Remote Similarity | NPD405 | Clinical (unspecified phase) |
0.689 | Remote Similarity | NPD2354 | Approved |
0.6889 | Remote Similarity | NPD7549 | Discontinued |
0.6884 | Remote Similarity | NPD2899 | Discontinued |
0.6879 | Remote Similarity | NPD6798 | Discontinued |
0.6863 | Remote Similarity | NPD2983 | Phase 2 |
0.6863 | Remote Similarity | NPD2982 | Phase 2 |
0.6863 | Remote Similarity | NPD4749 | Approved |
0.6859 | Remote Similarity | NPD7435 | Discontinued |
0.6857 | Remote Similarity | NPD7229 | Phase 3 |
0.6845 | Remote Similarity | NPD4361 | Phase 2 |
PubChem CID   | 96506 |
ChEMBL   | CHEMBL234338 |
ZINC   |
Molecular Weight:   | 302.04 |
ALogP:   | -2.8051 |
MLogP:   | 2.34 |
XLogP:   | 0.928 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 127.45 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 22 |